Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
US5152997A · kind A · utility
115Cited by
5References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 1991 |
| Grant date | Oct 6, 1992 |
| Priority date | — |
| Expiry date | Feb 7, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/7084
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Testosterone is administered transdermally through nonscrotal skin in a manner that mimics in amount and profile the natural production of testosterone in young adult healthy males. The testosterone is administered to the skin from a matrix which contains testosterone at subsaturation concentration and a permeation enhancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.